Valerian Aqueous Extract.

Valerian and hops have been formulated as a fixed combination in European sleep preparations for decades. Valerenic acid modulates the beta subunit of the GABA-A receptor while hop bitter acids act on GABA and melatonin receptor signalling.

Lemon balm rosmarinic acid inhibits GABA transaminase, so more GABA stays in the synapse, which complements the receptor-side modulation of valerenic acid. The two are a long-standing European combination.

Passiflora flavonoids act on GABA-A binding and GABA uptake, the same inhibitory system valerenic acid modulates. It is one of the standard third members of a valerian sleep blend.

Melatonin acts on MT1 and MT2 receptors to shift circadian timing while valerian acts on inhibitory neurotransmission. One handles when sleep starts, the other handles how readily it comes on.

Theanine modulates glutamate receptor binding and raises alpha-band activity, lowering excitatory tone from a direction different to the GABA-A modulation of valerenic acid.

Magnesium blocks the NMDA receptor channel and positively modulates GABA-A, and the glycine carrier is itself an inhibitory transmitter. It is the standard mineral base under a valerian sleep formula.

Glycine acts at its own inhibitory receptor and lowers core body temperature through peripheral vasodilation, the normal signal that precedes sleep onset. That is a separate route from GABA-A modulation.

Apigenin from chamomile binds the benzodiazepine site of the GABA-A receptor, a neighbouring site to where valerenic acid acts on the same complex.

Jujubosides and spinosin from sour date seed act on GABAergic and serotonergic sleep signalling, which overlaps with the inhibitory route valerenic acid works through. It is a common addition to valerian blends.

Kavalactones modulate GABA-A binding and block voltage-gated sodium channels, which layers directly onto the inhibitory action of valerian. The combined drowsiness is additive, so total load and timing matter.

Valerenic acid from valerian root behaves as a partial modulator at the beta subunit of the GABA-A receptor, and water extraction also carries free GABA and glutamine out of the root. Supplemental GABA is poorly transported across the blood brain barrier in adults, so most of any combined effect is likely receptor-side rather than additive transmitter loading. The pairing is common in evening formulas and rests on shared pathway logic, not on a combination trial.

Apigenin, the flavone concentrated in chamomile, binds the benzodiazepine site of the GABA-A receptor with low affinity. Valerenic acid acts at the beta2 and beta3 subunits instead, so the two occupy separate sites on one receptor complex. Formulators pair them for that reason; the additive claim is mechanistic and has not been isolated in a human combination trial.

L-tryptophan is the dietary precursor for serotonin and, downstream, melatonin, which is a different lever from valerian's receptor-side activity. Because the two do not compete for the same target, a formula can carry both without one blunting the other. Support for the pair is pathway reasoning rather than a head-to-head study.

5-HTP bypasses the rate-limiting hydroxylation step that governs tryptophan conversion, so it raises serotonin synthesis capacity more directly. Paired with valerian it addresses a separate signalling route in normal sleep onset. Sedation from the two may stack, which belongs on a label; no combination trial has measured the pair.

Honokiol and magnolol act as positive modulators at GABA-A receptors, the same complex valerenic acid touches. Stacking two modulators of one receptor may produce more drowsiness than either alone, which is the intended effect at night and an unwanted one during the day. Dose the pair for evening use and expect the sedative component to add.

Ashwagandha root extracts show GABA-mimetic activity in receptor work and are widely used in evening formulas alongside valerian. The two act through overlapping inhibitory signalling, so calm and drowsiness tend to add rather than cancel. No combination trial isolates the pair, so this is a mechanism-level pairing.

Caffeine blocks adenosine A1 and A2A receptors to reduce sleep pressure, while valerian constituents interact with A1 signalling and GABA-A in the direction of increased inhibition. Taken close together the two oppose each other on the same axis. Separating them by time of day is the practical consequence, and this is settled pharmacology rather than a study finding.

Hyperforin in St John's wort is a potent activator of the pregnane X receptor, which induces CYP3A4 and P-glycoprotein. Anything cleared through that route, including co-administered botanicals and many prescription medicines, is turned over faster. Sedative effects may also stack, so the combination is worth flagging in both directions.

Hops cones and valerian root have been combined in European evening preparations for a long time and appear together in many modern sleep formulas. Both carry constituents with activity at inhibitory receptors. The pairing has more usage history behind it than isolated combination data, so it reads as a long-standing formulation practice rather than a tested combination.

Lavender oil constituents act on voltage-gated calcium channels and on serotonergic signalling rather than directly on the GABA-A beta subunit. That makes lavender a non-overlapping partner for valerian in an evening formula. Evidence for the pair is limited to shared use, not a combination trial.